Evidence map›Paper›PMID 31693068›Full record

ArticleAesthetic surgery journal2020

A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management.

Greg J Goodman, Mark R Magnusson, Peter Callan, Stefania Roberts, Sarah Hart, Cara B McDonald, Michael Clague, Alice Rudd, Philip S Bekhor, Steven Liew and 12 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Aesthetic surgery journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 3 countries.

Greg J GoodmanMonash University and Chief of Surgery at the Skin and Cancer Foundation, Victoria, Australia.
Mark R MagnussonGriffiths University, Southport, Queensland, Australia.
Peter Callan
Stefania Roberts
Sarah Hart
Cara B McDonaldSt. Vincent's Hospital, Melbourne, Australia.
Michael Clague
Alice RuddAlfred Hospital, Prahran, Victoria, Australia.
Philip S BekhorUniversity of Melbourne, Department of Paediatrics and Director of the Laser Unit, Department of Dermatology, Royal Childrens' Hospital, Parkville, Victoria, Australia.
Steven Liew
Michael Molton
Katy Wallace
Niamh Corduff
Sean ArendseAlfred Hospital, Melbourne, Victoria, Australia.
Shobhan Manoharan
Ava Shamban
Izolda Heydenrych
Ashish C BhatiaNorthwestern University, Chicago, IL.
Peter Peng
Tatjana Pavicic
Krishan Mohan KapoorDepartment of Plastic Surgery, Fortis Hospital, Mohali, India.
David E Kosenko
The Alfred Hospital · AUFortis Hospital · INGriffith University · AUNorthwestern University · USRoyal Children's Hospital · AUSkin and Cancer Foundation · AUSt Vincent's Hospital Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyaluronic acid fillers have a satisfactory safety profile. However, adverse reactions do occur, and rarely intravascular injection may lead to blindness. Currently there is no internationally recognized consensus on the prevention or management of blindness from hyaluronic acid filler.

objectivesThe authors sought to give guidance on how to minimize the risk and optimize the management of this rare but catastrophic adverse reaction.

methodsA multinational group of experts in cosmetic injectables from multiple disciplines convened to review current best practice and develop updated consensus recommendations for prevention and bedside intervention if visual loss occurs after cosmetic injection of hyaluronic acid filler.

resultsThe consensus group provided specific recommendations focusing on the consenting process, prevention, and early management of visual impairment related to intravascular hyaluronic acid filler injection.

conclusionsAlthough visual loss due to filler injections is rare, it is important that both patient and physician be aware of this risk. In this paper the authors describe methods and techniques available to reduce the risk and also document suggested initial management should a clinician find themselves in this situation. LEVEL OF EVIDENCE: 5:

Indexed as

Cosmetic TechniquesDermal FillersBlindnessHumansHyaluronic AcidDermal FillersHyaluronic Acid

Identifiers

PMID31693068
PMCPMC7427155
OpenAlexW2987833827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.